Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Thoracic Surgery

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 319 articles:
HTML format



Single Articles


    September 2021
  1. PETERS SAE, Kluin J
    Why do women do worse after coronary artery bypass grafting?
    Eur Heart J. 2021 Sep 15. pii: 6370651. doi: 10.1093.
    PubMed    


  2. ERLINGE D, Gotberg M
    We need intracoronary physiology guidance before percutaneous coronary intervention, but do we need it post-stenting?
    Eur Heart J. 2021 Sep 4. pii: 6364082. doi: 10.1093.
    PubMed    


    August 2021
  3. GALLI M, Angiolillo DJ
    Non-opioid analgesics in patients undergoing percutaneous coronary intervention: hype or hope?
    Eur Heart J. 2021 Aug 25. pii: 6357340. doi: 10.1093.
    PubMed    


  4. STEFANINI GG, Briguori C, Cao D, Baber U, et al
    Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
    Eur Heart J. 2021 Aug 23. pii: 6356261. doi: 10.1093.
    PubMed     Abstract available


  5. DAVIERWALA PM, Gao C, Thuijs DJFM, Wang R, et al
    Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease.
    Eur Heart J. 2021 Aug 18. pii: 6354120. doi: 10.1093.
    PubMed     Abstract available


  6. GHAREBAGHI N, Mehdizade H, Askari B, Mirza-Aghazadeh-Attari M, et al
    A bizarre foreign object in the heart: toothpick lodged in the tricuspid valve.
    Eur Heart J. 2021;42:2957.
    PubMed    


  7. GAUDINO M, Di Franco A, Alexander JH, Bakaeen F, et al
    Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data.
    Eur Heart J. 2021 Aug 2. pii: 6333765. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  8. GOROG DA, Navarese EP, Andreotti F
    Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention?
    Eur Heart J. 2021 Jul 29. pii: 6330652. doi: 10.1093.
    PubMed    


  9. COLLISON D, Didagelos M, Aetesam-Ur-Rahman M, Copt S, et al
    Post-stenting fractional flow reserve vs coronary angiography for optimisation of percutaneous coronary intervention: TARGET-FFR trial.
    Eur Heart J. 2021 Jul 19. pii: 6323924. doi: 10.1093.
    PubMed     Abstract available


  10. KHARBANDA RK
    Reflective learning on the role of cerebral embolic protection in TAVI patients?
    Eur Heart J. 2021;42:2680-2682.
    PubMed    


  11. MAMAS MA
    Decision making in percutaneous coronary intervention in patients with cancer: balancing ischaemic and bleeding risk.
    Eur Heart J. 2021 Jul 13. pii: 6319849. doi: 10.1093.
    PubMed    


  12. CHESSA M, Brida M, Gatzoulis MA, Diller GP, et al
    Emergency department management of patients with adult congenital heart disease: a consensus paper from the ESC Working Group on Adult Congenital Heart Disease, the European Society for Emergency Medicine (EUSEM), the European Association for Cardio-T
    Eur Heart J. 2021;42:2527-2535.
    PubMed     Abstract available


  13. KITAMURA M, Holzhey D, Thiele H, Abdel-Wahab M, et al
    Single leaflet BASILICA for bilateral coronary artery protection.
    Eur Heart J. 2021;42:2612.
    PubMed    


  14. ONO M, Garg S, Onuma Y, Serruys PW, et al
    Coronary artery bypass grafting versus percutaneous coronary intervention in ischaemic heart failure. Can reliable treatment decisions in high-risk patients be based on non-randomized data?
    Eur Heart J. 2021 Jul 1. pii: 6311994. doi: 10.1093.
    PubMed    


  15. OYETUNJI SO, Otto CM
    Transcatheter aortic valve implantation or replacement? Valve durability in the context of patient life expectancy.
    Eur Heart J. 2021 Jul 1. pii: 6311995. doi: 10.1093.
    PubMed    


    June 2021
  16. JORGENSEN TH, Thyregod HGH, Ihlemann N, Nissen H, et al
    Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement.
    Eur Heart J. 2021 Jun 28. pii: 6310288. doi: 10.1093.
    PubMed     Abstract available


  17. CREA F
    The Universal Definition of Heart Failure, risk prediction in cardiogenic shock, artificial intelligence in cardiac allograft rejection, and the genetics of dilated cardiomyopathy.
    Eur Heart J. 2021;42:2317-2320.
    PubMed    


  18. VETA M, van Diest PJ, Vink A
    Can automatic image analysis replace the pathologist in cardiac allograft rejection diagnosis?
    Eur Heart J. 2021;42:2370-2372.
    PubMed    


  19. PEYSTER EG, Arabyarmohammadi S, Janowczyk A, Azarianpour-Esfahani S, et al
    An automated computational image analysis pipeline for histological grading of cardiac allograft rejection.
    Eur Heart J. 2021;42:2356-2369.
    PubMed     Abstract available


  20. GOLIASCH G, Lang IM
    Impact of sex on the management and outcome of aortic stenosis patients: a female aortic valve stenosis paradox, and a call for personalized treatments?
    Eur Heart J. 2021 Jun 13. pii: 6297824. doi: 10.1093.
    PubMed    


    May 2021
  21. BULLUCK H, Paradies V, Barbato E, Baumbach A, et al
    Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardio
    Eur Heart J. 2021 May 31. pii: 6290281. doi: 10.1093.
    PubMed     Abstract available


  22. VOLZ S, Redfors B, Angeras O, Ioanes D, et al
    Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
    Eur Heart J. 2021 May 23. pii: 6282431. doi: 10.1093.
    PubMed     Abstract available


  23. BIENJONETTI-BOUDREAU D, Fleury MA, Voisine M, Paquin A, et al
    Impact of sex on the management and outcome of aortic stenosis patients.
    Eur Heart J. 2021 May 23. pii: 6282426. doi: 10.1093.
    PubMed     Abstract available


  24. HILDICK-SMITH D, Egred M, Banning A, Brunel P, et al
    The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN).
    Eur Heart J. 2021 May 18. pii: 6276782. doi: 10.1093.
    PubMed     Abstract available


  25. NAVARESE EP, Lansky AJ, Kereiakes DJ, Kubica J, et al
    Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis.
    Eur Heart J. 2021 May 18. pii: 6276780. doi: 10.1093.
    PubMed     Abstract available


  26. LANSKY AJ, Makkar R, Nazif T, Messe S, et al
    A randomized evaluation of the TriGuard HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.
    Eur Heart J. 2021 May 17. pii: 6277114. doi: 10.1093.
    PubMed     Abstract available


  27. LANSKY A, Chun H, Pietras C, Hussain Y, et al
    Refining drug-eluting stent technologies: from engineering to basic science.
    Eur Heart J. 2021;42:1770-1772.
    PubMed    


    April 2021
  28. GENEREUX P, Piazza N, Alu MC, Nazif T, et al
    Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research.
    Eur Heart J. 2021 Apr 19. pii: 6237954. doi: 10.1093.
    PubMed     Abstract available


  29. BODEN WE, Stone PH
    To stent or not to stent? Treating angina after ISCHEMIA-why a conservative approach with optimal medical therapy is the preferred initial management strategy for chronic coronary syndromes: insights from the ISCHEMIA trial.
    Eur Heart J. 2021;42:1394-1400.
    PubMed    


  30. GAUDINO M, Di Franco A, Bhatt DL, Alexander JH, et al
    The association between coronary graft patency and clinical status in patients with coronary artery disease.
    Eur Heart J. 2021;42:1433-1441.
    PubMed     Abstract available


  31. DING D, Huang J, Westra J, Cohen DJ, et al
    Immediate post-procedural functional assessment of percutaneous coronary intervention: current evidence and future directions.
    Eur Heart J. 2021 Apr 5. pii: 6211340. doi: 10.1093.
    PubMed     Abstract available


  32. TEN BERG J, Sibbing D, Rocca B, Van Belle E, et al
    Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in coll
    Eur Heart J. 2021 Apr 5. pii: 6210683. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  33. CREA F
    Challenges in heart failure: quality of life, chronic kidney disease, and secondary mitral regurgitation.
    Eur Heart J. 2021;42:1185-1189.
    PubMed    


  34. VITALE N, Lucarelli K, Di Bari N, Milano AD, et al
    Anomalous origin of a grafted left internal mammary artery from the deep brachial artery.
    Eur Heart J. 2021;42:1182.
    PubMed    


  35. KWOK CS, Wong CW, Kontopantelis E, Barac A, et al
    Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA.
    Eur Heart J. 2021;42:1019-1034.
    PubMed     Abstract available


  36. REED GW, Krishnaswamy A, Kapadia SR
    Silent brain infarction after TAVR: common but of unclear significance.
    Eur Heart J. 2021;42:1016-1018.
    PubMed    


  37. DIBIE A, Landolff Q, Veugeois A, Amabile N, et al
    Chimney technique in a TAVR-in-TAVR procedure with high risk of left main artery ostium occlusion.
    Eur Heart J. 2021;42:1051.
    PubMed    


    February 2021
  38. CAO D, Baber U, Mehran R
    Aspirin-free strategies: a framework to reassess the role of dual antiplatelet therapy after percutaneous coronary intervention.
    Eur Heart J. 2021 Feb 22. pii: 6146039. doi: 10.1093.
    PubMed    


  39. SCHOENRATH F, Just IA, Falk V, Emmert MY, et al
    Antiplatelet and direct oral anticoagulation management after coronary artery bypass graft surgery: the Cinderella of current cardiovascular trials, please show me (some) evidence.
    Eur Heart J. 2021 Feb 22. pii: 6146041. doi: 10.1093.
    PubMed    


  40. CASE BC, Ben-Dor I, Satler LF, Waksman R, et al
    Rescue alcohol septal ablation for dynamic left ventricular outflow tract obstruction and haemodynamic collapse after transcatheter aortic valve implantation.
    Eur Heart J. 2021 Feb 21. pii: 6145857. doi: 10.1093.
    PubMed    


  41. DIAZ-RODRIGUEZ S, Rasser C, Mesnier J, Chevallier P, et al
    Coronary stent CD31-mimetic coating favours endothelialization and reduces local inflammation and neointimal development in vivo.
    Eur Heart J. 2021 Feb 13. pii: 6134553. doi: 10.1093.
    PubMed     Abstract available


  42. SAWANO S, Nakayama A, Morita H, Komuro I, et al
    Rathke's cleft cyst induced cardiac arrest.
    Eur Heart J. 2021;42:714.
    PubMed    


  43. LIUZZO G, Patrono C
    When less is more: dual antiplatelet therapy in elective percutaneous coronary intervention.
    Eur Heart J. 2021 Feb 8. pii: 6130737. doi: 10.1093.
    PubMed    


  44. CREA F
    Focus on atrial fibrillation, syncope, and arrhythmias during COVID-19 pandemic.
    Eur Heart J. 2021;42:361-364.
    PubMed    


  45. WOLDENDORP K, Indja B, Bannon PG, Fanning JP, et al
    Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.
    Eur Heart J. 2021 Feb 1. pii: 6124789. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  46. VAN DER SANGEN NMR, Rozemeijer R, Chan Pin Yin DRPP, Valgimigli M, et al
    Patient-tailored antithrombotic therapy following percutaneous coronary intervention.
    Eur Heart J. 2021 Jan 29. pii: 6122862. doi: 10.1093/eurheartj/ehaa1097.
    PubMed     Abstract available


  47. LUNARDI M, Onuma Y, Serruys PW
    Ticagrelor monotherapy following percutaneous coronary intervention for acute coronary syndrome in TWILIGHT patients: still a future for aspirin?
    Eur Heart J. 2021 Jan 27. pii: 6121205. doi: 10.1093.
    PubMed    


  48. BERGMARK BA, Morrow DA
    Cardiac troponin elevation after elective PCI: adding infarct to major injury.
    Eur Heart J. 2021;42:335-338.
    PubMed    


  49. QUERCIOLI A, Capettini AC, Gherli R, Secco GG, et al
    Three-dimensional echo guidance of percutaneous mitral paravalvular leak closure.
    Eur Heart J. 2021;42:359.
    PubMed    


  50. GOPALAMURUGAN AB, Anantharaman R, Abubacker M, Varshaa GM, et al
    First-in-man proof of feasibility: PCI, TAVR, and TEVAR of aortic arch with a hybrid approach through a trans-caval (cavo-aortic) access in the same procedure.
    Eur Heart J. 2021;42:357.
    PubMed    


  51. GUPTA A, Chhikara S
    Significant pinching of dominant left circumflex artery during provisional left main bifurcation angioplasty: what next?
    Eur Heart J. 2021;42:285.
    PubMed    


  52. DAVIES A, Fox K, Galassi AR, Banai S, et al
    Management of refractory angina: an update.
    Eur Heart J. 2021;42:269-283.
    PubMed     Abstract available



  53. Corrigendum to: Clinical and Conceptual Approaches to interpreting the findings of Systematic Review and Meta-Analysis of Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease.
    Eur Heart J. 2021 Jan 17. pii: 6103211. doi: 10.1093/eurheartj/ehaa1092.
    PubMed    


  54. NICHOLLS M
    The Year in Cardiovascular Medicine 2020: Coronary Intervention.
    Eur Heart J. 2021 Jan 17. pii: 6103209. doi: 10.1093/eurheartj/ehaa1021.
    PubMed    


  55. PEREZ DE ISLA L, Watts GF, Alonso R, Diaz-Diaz JL, et al
    Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.
    Eur Heart J. 2021 Jan 12. pii: 6091158. doi: 10.1093/eurheartj/ehaa1066.
    PubMed     Abstract available


    December 2020
  56. CAO D, Chandiramani R, Chiarito M, Claessen BE, et al
    Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey.
    Eur Heart J. 2020 Dec 26. pii: 6050475. doi: 10.1093.
    PubMed     Abstract available


  57. CORTESE F, Magli M, Di Marino S
    A floating thrombus in the ascending aorta, as a complication of a percutaneous coronary angiography.
    Eur Heart J. 2020 Dec 14. pii: 6034852. doi: 10.1093/eurheartj/ehaa1001.
    PubMed    


  58. CHEN J, Wei L, Wang C
    The impact of minimally invasive technique on the outcomes of isolated tricuspid valve surgery.
    Eur Heart J. 2020 Dec 12. pii: 6031686. doi: 10.1093.
    PubMed    


  59. GIACOPPO D, Matsuda Y, Fovino LN, D'Amico G, et al
    Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized cl
    Eur Heart J. 2020 Dec 7. pii: 6025040. doi: 10.1093.
    PubMed     Abstract available


  60. GALIUTO L, Patrono C
    Aspirin Monotherapy vs. DAPT after TAVI: Is Less More? Comment on the POPular TAVI Trial.
    Eur Heart J. 2020;41:4301-4302.
    PubMed    


    November 2020
  61. SILVAIN J, Zeitouni M, Paradies V, Zheng HL, et al
    Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data.
    Eur Heart J. 2020 Nov 30. pii: 6012927. doi: 10.1093.
    PubMed     Abstract available


  62. VERDECCHIA P, Angeli F, Cavallini C
    Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation.
    Eur Heart J. 2020 Nov 9. pii: 5964168. doi: 10.1093.
    PubMed    


  63. SHARMA A, Bertog S, Mbai M
    Transcatheter aortic valve lithotripsy in severely calcified bicuspid aortic stenosis prior to transcatheter aortic valve implantation.
    Eur Heart J. 2020 Nov 6. pii: 5959818. doi: 10.1093.
    PubMed    


    October 2020
  64. FANAROFF AC, Lopes RD
    Antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: balance best with double antithrombotic therapy.
    Eur Heart J. 2020 Oct 25. pii: 5939783. doi: 10.1093.
    PubMed    


  65. DREYFUS G, Windecker S
    How to shape the future of cardiology and cardiac surgery?
    Eur Heart J. 2020 Oct 16. pii: 5925735. doi: 10.1093.
    PubMed    


  66. CHEN SL
    In the face of cunning enemy: DK crush writes legend.
    Eur Heart J. 2020;41:3763-3764.
    PubMed    


  67. BABER U, Dangas G, Angiolillo DJ, Cohen DJ, et al
    Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.
    Eur Heart J. 2020;41:3533-3545.
    PubMed     Abstract available


    September 2020
  68. DREYFUS J, Flagiello M, Bazire B, Eggenspieler F, et al
    Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes.
    Eur Heart J. 2020 Sep 25. pii: 5911419. doi: 10.1093.
    PubMed     Abstract available


  69. BAUMGARTNER H, Iung B, Otto CM
    Timing of intervention in asymptomatic patients with valvular heart disease.
    Eur Heart J. 2020 Sep 9. pii: 5903163. doi: 10.1093.
    PubMed     Abstract available


  70. WALTERSCHEID B, Nguyen J, Tarbox M, Eshak N, et al
    Clopidogrel-induced sweet syndrome: severe dermatological complication after percutaneous coronary intervention.
    Eur Heart J. 2020 Sep 4. pii: 5901663. doi: 10.1093.
    PubMed    


  71. NG ACT, Holmes DR, Mack MJ, Delgado V, et al
    Leaflet immobility and thrombosis in transcatheter aortic valve replacement.
    Eur Heart J. 2020;41:3184-3197.
    PubMed     Abstract available


    August 2020
  72. VRANCKX P, Valgimigli M, Eckardt L, Lewalter T, et al
    Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial.
    Eur Heart J. 2020 Aug 29. pii: 5898835. doi: 10.1093.
    PubMed     Abstract available


  73. HINDRICKS G, Potpara T, Dagres N, Arbelo E, et al
    2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).
    Eur Heart J. 2020 Aug 29. pii: 5899003. doi: 10.1093.
    PubMed    


  74. RIMAC G, Marzouk M, Dumont E, Paradis JM, et al
    When a delayed cardiology consultation leads to a massive left ventricle pseudoaneurysm: collateral effects of the COVID-19 pandemic.
    Eur Heart J. 2020;41:3102.
    PubMed    


  75. FERLINI M, Mauri S
    Variable rate of stroke after transcatheter aortic valve replacement with self-expandable valves: more doubts than certainties.
    Eur Heart J. 2020 Aug 18. pii: 5893661. doi: 10.1093.
    PubMed    


  76. THIELE H, Abdel-Wahab M, Desch S
    Stroke rates after transcatheter aortic valve replacement: does valve choice play a role?
    Eur Heart J. 2020 Aug 18. pii: 5893660. doi: 10.1093.
    PubMed    


  77. TARANTINI G, Cardaioli F, Pavei A, Fabris T, et al
    Unfolding of unexpected and extreme transcatheter aortic valve distortion.
    Eur Heart J. 2020 Aug 18. pii: 5893662. doi: 10.1093.
    PubMed    


  78. MATSUSHITA K, Hess S, Ohlmann P, Morel O, et al
    Accordion phenomenon in the descending aorta during transcatheter aortic valve replacement followed by mesenteric ischaemia.
    Eur Heart J. 2020;41:2819.
    PubMed    


  79. MOHTY D, Pibarot P, Damy T
    Aortic stenosis and amyloid heart disease: 'the 2A dangerous liaisons'.
    Eur Heart J. 2020;41:2815.
    PubMed    


  80. BAUMGARTNER H
    Transcatheter valve-in-valve implantation in failed aortic bioprosthetic valves: a word of caution in times of euphoria.
    Eur Heart J. 2020;41:2743-2746.
    PubMed    


  81. LUSCHER TF
    Frontiers in valvular heart disease: outcomes of novel percutaneous procedures.
    Eur Heart J. 2020;41:2717-2720.
    PubMed    


    July 2020
  82. BEIRAS-FERNANDEZ A, Ruf TF, Obadia JI, Munzel T, et al
    Neochord anterior leaflet treatment to facilitate transcatheter mitral valve replacement with 3D real-time echocardiography.
    Eur Heart J. 2020 Jul 29. pii: 5877565. doi: 10.1093.
    PubMed    


  83. GILMANOV D, Greco C, Cafaro A, Zaccaria S, et al
    Two coronary artery aneurysms complicated by acute myocardial infarction and treated with open chest surgery.
    Eur Heart J. 2020 Jul 29. pii: 5877568. doi: 10.1093.
    PubMed    


  84. HOWARD JP, Arnold AD, Ahmad Y
    Bias, heterogeneity, and uncertainty in meta-analysis.
    Eur Heart J. 2020;41:2712.
    PubMed    


  85. HIRJI S, Zogg CK, Kaneko T
    The utility of the nationwide readmissions database in understanding contemporary transcatheter aortic valve replacement outcomes.
    Eur Heart J. 2020 Jul 17. pii: 5873282. doi: 10.1093.
    PubMed    


  86. NAZIR S, Ahuja KR, Alamir MA
    Is the national readmission database the right database to identify valve-in-valve transcatheter aortic valve replacement patients?
    Eur Heart J. 2020 Jul 17. pii: 5873284. doi: 10.1093.
    PubMed    


  87. SADEGHI AH, Taverne YJHJ, Bogers AJJC, Mahtab EAF, et al
    Immersive virtual reality surgical planning of minimally invasive coronary artery bypass for Kawasaki disease.
    Eur Heart J. 2020 Jul 8. pii: 5868577. doi: 10.1093.
    PubMed    


  88. FALK RH, Dorbala S
    Transthyretin cardiac amyloidosis in patients with severe aortic stenosis.
    Eur Heart J. 2020 Jul 8. pii: 5868579. doi: 10.1093.
    PubMed    


  89. FERENC M, Neumann FJ
    Towards a lesion-specific approach to percutaneous coronary intervention for bifurcation lesions.
    Eur Heart J. 2020 Jul 3. pii: 5866891. doi: 10.1093.
    PubMed    


    June 2020
  90. ROMMEL KP, Lurz P
    Transcatheter tricuspid valve repair and pulmonary hypertension: navigating through troubled waters.
    Eur Heart J. 2020 Jun 30. pii: 5865477. doi: 10.1093.
    PubMed    


  91. D'ALTO M, Naeije R
    Transcatheter tricuspid valve repair in patients with pulmonary hypertension.
    Eur Heart J. 2020 Jun 30. pii: 5865473. doi: 10.1093.
    PubMed    


  92. BLEIZIFFER S, Simonato M, Webb JG, Rodes-Cabau J, et al
    Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves.
    Eur Heart J. 2020 Jun 27. pii: 5863929. doi: 10.1093.
    PubMed     Abstract available


  93. JAYARAJ R, Kumaraswamy C, Shaw P
    Clinical and conceptual approaches to interpreting the findings of systematic review and meta-analysis of mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease.
    Eur Heart J. 2020 Jun 26. pii: 5863013. doi: 10.1093.
    PubMed    


  94. IUNG B, Wendler O
    Valve-in-valve vs. repeat surgical aortic valve replacement: a new match but the game is not over!
    Eur Heart J. 2020 Jun 12. pii: 5856871. doi: 10.1093.
    PubMed    


  95. HUA A, O'Gallagher K, Sado D, Byrne J, et al
    Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19.
    Eur Heart J. 2020;41:2130.
    PubMed    


  96. VARELA-CANCELO A, Salgado-Fernandez J, Calvino-Santos R, Bouzas-Zubeldia B, et al
    Successful transfemoral management of transcatheter aortic valve embolization into left ventricle.
    Eur Heart J. 2020 Jun 4. pii: 5851539. doi: 10.1093.
    PubMed    


    May 2020
  97. HIRJI SA, Percy ED, Zogg CK, Malarczyk A, et al
    Comparison of in-hospital outcomes and readmissions for valve-in-valve transcatheter aortic valve replacement vs. reoperative surgical aortic valve replacement: a contemporary assessment of real-world outcomes.
    Eur Heart J. 2020 May 23. pii: 5841644. doi: 10.1093.
    PubMed     Abstract available


  98. WEBB J, Wood D, Sathananthan J, Landes U, et al
    Balloon-expandable or self-expandable transcatheter heart valves. Which are best?
    Eur Heart J. 2020;41:1900-1902.
    PubMed    


  99. HUBER K, Ulmer H, Lang IM, Muhlberger V, et al
    Coronary interventions in Austria, Germany, and Switzerland.
    Eur Heart J. 2020 May 8. pii: 5834923. doi: 10.1093.
    PubMed    


  100. GAUDINO M, Freemantle N, Farkouh ME
    The conundrum of the treatment for left main coronary disease.
    Eur Heart J. 2020 May 5. pii: 5830808. doi: 10.1093.
    PubMed    


  101. BJORNSTAD JL, Bendz B
    Periprocedural myocardial injury in the EXCEL trial.
    Eur Heart J. 2020;41:1703.
    PubMed    


    April 2020
  102. SATO T, Konishi T, Wakasa S, Oyama-Manabe N, et al
    Phosphoglyceride crystal deposition disease as a rare tumour after cardiac surgery.
    Eur Heart J. 2020 Apr 26. pii: 5825471. doi: 10.1093.
    PubMed    


  103. CHEN Y, Waksman R, Satler L, Barnett C, et al
    Percutaneous transcatheter release of stuck mechanical mitral valve leaflet.
    Eur Heart J. 2020 Apr 20. pii: 5822833. doi: 10.1093.
    PubMed    


  104. MURAKAMI T, Ohno Y, Nakazawa G, Ikari Y, et al
    Transjugular intracardiac echocardiography-guided transcatheter aortic valve implantation.
    Eur Heart J. 2020 Apr 14. pii: 5819673. doi: 10.1093.
    PubMed    


  105. SCULLY PR, Patel KP, Treibel TA, Thornton GD, et al
    Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation.
    Eur Heart J. 2020 Apr 8. pii: 5817909. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  106. STONE GW, Ben-Yehuda O, Sabik JF, Kappetein AP, et al
    Considerations for an optimal definition of procedural myocardial infarction.
    Eur Heart J. 2020 Mar 30. pii: 5813684. doi: 10.1093.
    PubMed    


  107. KONG WKF, Bax JJ, Delgado V
    Left ventricular myocardial fibrosis: a marker of bad prognosis in symptomatic severe aortic stenosis.
    Eur Heart J. 2020 Mar 24. pii: 5811373. doi: 10.1093.
    PubMed    


  108. LURZ P, Orban M, Besler C, Braun D, et al
    Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair.
    Eur Heart J. 2020 Mar 16. pii: 5807655. doi: 10.1093.
    PubMed     Abstract available


  109. ALVAREZ-COVARRUBIAS HA, Xhepa E, Michel JM, Kasel AM, et al
    1000 mm2 plus aortic annulus: successful treatment of a giant bicuspid aortic valve with a Sapien 3 transcatheter heart valve.
    Eur Heart J. 2020 Mar 10. pii: 5802606. doi: 10.1093.
    PubMed    


  110. SCHMIADY MO, Taramasso M, Maisano F, Sigler M, et al
    Mitral valve surgery after MitraClip(R) implantation: what histopathology can tell us?
    Eur Heart J. 2020 Mar 6. pii: 5788531. doi: 10.1093.
    PubMed    


  111. AHMAD Y, Howard JP, Arnold AD, Cook CM, et al
    Mortality after drug-eluting stents vs. coronary artery bypass grafting for left main coronary artery disease: a meta-analysis of randomized controlled trials.
    Eur Heart J. 2020 Mar 2. pii: 5771278. doi: 10.1093.
    PubMed     Abstract available


  112. MESSERLI FH, Bangalore S, Messerli AW, Raber L, et al
    The muddy waters of the J-curve and coronary revascularization.
    Eur Heart J. 2020 Mar 2. pii: 5771269. doi: 10.1093.
    PubMed    


    February 2020
  113. JERING KS, Pfeffer MA
    From practice changing to hypothesis generating: a virtuous cycle.
    Eur Heart J. 2020;41:955-957.
    PubMed    


  114. KHOR L, Simmons LA, Von Bardeleben RS, Ng MK, et al
    Transcatheter edge-to-edge repair for tricuspid regurgitation in Barlow-type tricuspid valve prolapse.
    Eur Heart J. 2020 Feb 20. pii: 5741384. doi: 10.1093.
    PubMed    


  115. AGASTHI P, Tseng A, Mulpuru SK
    Appropriate cohort selection and its impact on a meta-analysis evaluating the efficacy of direct oral anticoagulants post-percutaneous coronary intervention.
    Eur Heart J. 2020 Feb 14. pii: 5736264. doi: 10.1093.
    PubMed    


  116. THIELE H, Kurz T, Feistritzer HJ, Stachel G, et al
    Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial.
    Eur Heart J. 2020 Feb 12. pii: 5734668. doi: 10.1093.
    PubMed     Abstract available


  117. PULS M, Beuthner BE, Topci R, Vogelgesang A, et al
    Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis.
    Eur Heart J. 2020 Feb 12. pii: 5734676. doi: 10.1093.
    PubMed     Abstract available


  118. HAMM CW, Beyersdorf F
    GARY-The Largest Registry of Aortic Stenosis Treatment Worldwide.
    Eur Heart J. 2020;41:733-735.
    PubMed    


    January 2020
  119. AUFFRET V, Puri R, Leurent G, Le Breton H, et al
    Conduction disturbances following trancatheter aortic valve implantation: increasing the 'pace' towards prospective evidence.
    Eur Heart J. 2020 Jan 20. pii: 5710689. doi: 10.1093.
    PubMed    


  120. OZKAN J
    Bernhard Meier MD FACC FESC.
    Eur Heart J. 2020;41:340-342.
    PubMed    


  121. RUBATTU S, Volpe M
    BNP level and post-transcatheter aortic valve replacement outcome: an intriguing J-shaped relationship.
    Eur Heart J. 2020 Jan 6. pii: 5697062. doi: 10.1093.
    PubMed    


  122. TESTA L, Latib A, Brambilla N, De Marco F, et al
    Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis.
    Eur Heart J. 2020 Jan 6. pii: 5697056. doi: 10.1093.
    PubMed     Abstract available


  123. BAUMBACH A, Bourantas CV, Serruys PW, Wijns W, et al
    The year in cardiology: coronary interventions.
    Eur Heart J. 2020 Jan 6. pii: 5694318. doi: 10.1093.
    PubMed    


  124. SONDERGAARD L
    Durability of transcatheter bioprosthetic aortic valves.
    Eur Heart J. 2020 Jan 6. pii: 5697053. doi: 10.1093.
    PubMed    


  125. FAROUX L, Chen S, Muntane-Carol G, Regueiro A, et al
    Clinical impact of conduction disturbances in transcatheter aortic valve replacement recipients: a systematic review and meta-analysis.
    Eur Heart J. 2020 Jan 3. pii: 5695667. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  126. PAVASINI R, Biscaglia S, Barbato E, Tebaldi M, et al
    Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials.
    Eur Heart J. 2019 Dec 31. pii: 5692630. doi: 10.1093.
    PubMed     Abstract available


  127. CHEN S, Redfors B, O'Neill BP, Clavel MA, et al
    Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry.
    Eur Heart J. 2019 Dec 28. pii: 5688929. doi: 10.1093.
    PubMed     Abstract available


  128. STOREY RF, Valgimigli M, Cuisset T, Capodanno D, et al
    Intolerance to aspirin in patients undergoing percutaneous coronary intervention in the setting of chronic coronary syndromes: perspectives from the ESC 2019 Chronic Coronary Syndromes guidelines.
    Eur Heart J. 2019 Dec 23. pii: 5686014. doi: 10.1093.
    PubMed    


  129. KOGAME N, Serruys PW, Onuma Y
    Cracking (the code of) coronary artery calcification to win the last battle of percutaneous coronary intervention: still in the middle of a rocky road.
    Eur Heart J. 2019 Dec 23. pii: 5686015. doi: 10.1093.
    PubMed    


  130. WELSH RC
    Applying evidence-based antiplatelet therapy in patients following a myocardial infarction without percutaneous coronary revascularization.
    Eur Heart J. 2019 Dec 23. pii: 5686009. doi: 10.1093.
    PubMed    


  131. SIA CH, Gochuico CFS, Ong CC, Teo LL, et al
    A man with end-stage renal failure and uncontrolled hyperparathyroidism with repeat transcatheter aortic valve replacement in a surgical bioprosthetic aortic valve while avoiding patient-prosthesis mismatch.
    Eur Heart J. 2019 Dec 22. pii: 5684840. doi: 10.1093.
    PubMed    


  132. FURTADO RHM, Nicolau JC, Magnani G, Im K, et al
    Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.
    Eur Heart J. 2019 Dec 7. pii: 5663567. doi: 10.1093.
    PubMed     Abstract available


  133. LOPEZ-JIMENEZ F, Gersh BJ
    Secondary prevention after coronary artery bypass grafting saves lives: a golden opportunity often wasted.
    Eur Heart J. 2019 Dec 4. pii: 5651910. doi: 10.1093.
    PubMed    


  134. YERASI C, O'Donoghue S, Satler LF, Waksman R, et al
    Apple Watch detecting high-grade block after transcatheter aortic valve implantation.
    Eur Heart J. 2019 Dec 3. pii: 5651110. doi: 10.1093.
    PubMed    


    November 2019
  135. LOPES RD, Hong H, Alexander JH
    Antithrombotic therapy after acute coronary syndrome and/or percutaneous coronary intervention in atrial fibrillation: finding the sweet spot.
    Eur Heart J. 2019 Nov 27. pii: 5644218. doi: 10.1093.
    PubMed    


  136. EBERHARD M, Hermann M, Stahli BE, Manka R, et al
    Amphetamine-induced coronary artery dissection and massive aortic valve thrombus.
    Eur Heart J. 2019 Nov 25. pii: 5640488. doi: 10.1093.
    PubMed    


  137. CHEN S, Redfors B, Nazif T, Kirtane A, et al
    Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries.
    Eur Heart J. 2019 Nov 11. pii: 5621355. doi: 10.1093.
    PubMed     Abstract available


  138. RUMPF PM, Michel JM, Xhepa E, Kasel AM, et al
    Paravalvular leakage due to ring dehiscence after mitral valve-in-ring therapy: mechanisms and percutaneous treatment.
    Eur Heart J. 2019 Nov 5. pii: 5613227. doi: 10.1093.
    PubMed    


    October 2019
  139. GARGIULO G, Goette A, Tijssen J, Eckardt L, et al
    Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based rand
    Eur Heart J. 2019 Oct 25. pii: 5607287. doi: 10.1093.
    PubMed     Abstract available


  140. BJORKLUND E, Nielsen SJ, Hansson EC, Karlsson M, et al
    Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry.
    Eur Heart J. 2019 Oct 22. pii: 5602556. doi: 10.1093.
    PubMed     Abstract available


  141. SYBURRA MT, Guettler N, D'Arcy JL, Nicol ED, et al
    Clinical occupational assessment pre- and post-cardiac surgery.
    Eur Heart J. 2019;40:3283-3286.
    PubMed    


  142. LIN AE, Libby P, Ebert BL
    A new opening on aortic stenosis: predicting prognosis with clonal haematopoiesis.
    Eur Heart J. 2019 Oct 21. pii: 5601845. doi: 10.1093.
    PubMed    


  143. MONTEAGUDO RUIZ JM, Zamorano Gomez JL
    Endocarditis after transcatheter aortic valve implantation: a new fiend we hardly know.
    Eur Heart J. 2019 Oct 7. pii: 5583201. doi: 10.1093.
    PubMed    


    September 2019
  144. ABDEL-WAHAB M, Kitamura M, Holzhey D, Thiele H, et al
    Transcatheter aortic valve implantation with a new generation mechanically expanding valve in a patient with a protruding coronary stent into the sinus of Valsalva: the 'reversed-chimney' technique.
    Eur Heart J. 2019 Sep 24. pii: 5573049. doi: 10.1093.
    PubMed    


  145. MESSIKA-ZEITOUN D, Vahanian A, Verta P, Maisano F, et al
    Perspective on the treatment of functional mitral regurgitation using the Cardioband System.
    Eur Heart J. 2019 Sep 9. pii: 5566426. doi: 10.1093.
    PubMed    


  146. MAS-PEIRO S, Hoffmann J, Fichtlscherer S, Dorsheimer L, et al
    Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation.
    Eur Heart J. 2019 Sep 3. pii: 5554424. doi: 10.1093.
    PubMed     Abstract available


  147. THRANE PG, Kristensen SD, Olesen KKW, Mortensen LS, et al
    16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.
    Eur Heart J. 2019 Sep 2. pii: 5554441. doi: 10.1093.
    PubMed     Abstract available


    August 2019
  148. BJURSTEN H, Rasmussen M, Nozohoor S, Gotberg M, et al
    Infective endocarditis after transcatheter aortic valve implantation: a nationwide study.
    Eur Heart J. 2019 Aug 21. pii: 5552575. doi: 10.1093.
    PubMed     Abstract available


  149. LUSCHER TF
    Refining percutaneous coronary intervention: intracoronary imaging, haemodynamics, P2Y12 antagonists, and public outcomes reporting.
    Eur Heart J. 2019;40:2549-2552.
    PubMed    


  150. SERRUYS PW, Takahashi K, Chichareon P, Kogame N, et al
    Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
    Eur Heart J. 2019;40:2595-2604.
    PubMed     Abstract available


  151. ALKHOULI M, Alqahtani F, Ziada KM, Aljohani S, et al
    Contemporary trends in the management of aortic stenosis in the USA.
    Eur Heart J. 2019 Aug 13. pii: 5549415. doi: 10.1093.
    PubMed     Abstract available


  152. CALISKAN E, Falk V, Emmert MY
    Multiarterial grafting in coronary artery bypass grafting.
    Eur Heart J. 2019;40:2479-2481.
    PubMed    


  153. LE PAGE PT, Bellenger NG
    Completeness of revascularization: should we not consider assessment before and after coronary artery bypass grafting?
    Eur Heart J. 2019 Aug 7. pii: 5544747. doi: 10.1093.
    PubMed    


    July 2019
  154. NAZIF TM, Chen S, George I, Dizon JM, et al
    New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial.
    Eur Heart J. 2019;40:2218-2227.
    PubMed     Abstract available


    June 2019
  155. CONEN D, Alonso-Coello P, Douketis J, Chan MTV, et al
    Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery.
    Eur Heart J. 2019 Jun 25. pii: 5523034. doi: 10.1093.
    PubMed     Abstract available


  156. KOTECHA D, Castella M
    Is it time to treat post-operative atrial fibrillation just like regular atrial fibrillation?
    Eur Heart J. 2019 Jun 25. pii: 5523037. doi: 10.1093.
    PubMed    


  157. POZZOLI A, Gavazzoni M, Maisano F, Taramasso M, et al
    Transcatheter mitral valve replacement after transcatheter direct annuloplasty with Cardioband.
    Eur Heart J. 2019 Jun 5. pii: 5511702. doi: 10.1093.
    PubMed    


  158. TOZZI P
    The future of functional mitral regurgitation treatment.
    Eur Heart J. 2019 Jun 5. pii: 5511705. doi: 10.1093.
    PubMed    


    May 2019
  159. SCHUNKERT H, Boening A, von Scheidt M, Lanig C, et al
    Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial.
    Eur Heart J. 2019 May 30. pii: 5506732. doi: 10.1093.
    PubMed     Abstract available


  160. ARBEL Y, Ben-Assa E, Puzhevsky D, Litmanowicz B, et al
    Forced diuresis with matched hydration during transcatheter aortic valve implantation for Reducing Acute Kidney Injury: a randomized, sham-controlled study (REDUCE-AKI).
    Eur Heart J. 2019 May 23. pii: 5497106. doi: 10.1093.
    PubMed     Abstract available


  161. URBAN P, Mehran R, Colleran R, Angiolillo DJ, et al
    Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk.
    Eur Heart J. 2019 May 22. pii: 5492739. doi: 10.1093.
    PubMed     Abstract available


  162. PETRUS AHJ, Dekkers OM, Tops LF, Timmer E, et al
    Impact of recurrent mitral regurgitation after mitral valve repair for functional mitral regurgitation: long-term analysis of competing outcomes.
    Eur Heart J. 2019 May 21. pii: 5494552. doi: 10.1093.
    PubMed     Abstract available


  163. DEVEREAUX PJ, Szczeklik W
    Myocardial injury after non-cardiac surgery: diagnosis and management.
    Eur Heart J. 2019 May 16. pii: 5490290. doi: 10.1093.
    PubMed     Abstract available


  164. MYERS PO, Nguyen-Tang T, Alibegovic-Zaza J, Inan I, et al
    Spontaneous haemorrhage on apixaban masquerading as obstructive cholangitis after heart surgery.
    Eur Heart J. 2019 May 9. pii: 5487606. doi: 10.1093.
    PubMed    


  165. URENA M, Rodes-Cabau J
    New-onset conduction disturbances: the last obstacle in the way of transcatheter aortic valve implantation.
    Eur Heart J. 2019 May 9. pii: 5487604. doi: 10.1093.
    PubMed    


  166. GATZOULIS KA, Tsiachris D, Arsenos P, Antoniou CK, et al
    Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.
    Eur Heart J. 2019 May 3. pii: 5485105. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  167. SIONTIS GCM, Overtchouk P, Cahill TJ, Modine T, et al
    Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis.
    Eur Heart J. 2019 Apr 23. pii: 5477387. doi: 10.1093.
    PubMed     Abstract available


  168. KASPRZAK JD, Pawlowski J, Peruga JZ, Kaminski J, et al
    First-in-man experience with real-time holographic mixed reality display of three-dimensional echocardiography during structural intervention: balloon mitral commissurotomy.
    Eur Heart J. 2019 Apr 12. pii: 5449042. doi: 10.1093.
    PubMed    


  169. JONES DA, Rathod KS, Koganti S, Lim P, et al
    The association between the public reporting of individual operator outcomes with patient profiles, procedural management, and mortality after percutaneous coronary intervention: an observational study from the Pan-London PCI (BCIS) Registry using an
    Eur Heart J. 2019 Apr 10. pii: 5443278. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  170. BEN-YEHUDA O, Chen S, Redfors B, McAndrew T, et al
    Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
    Eur Heart J. 2019 Mar 28. pii: 5421317. doi: 10.1093.
    PubMed     Abstract available


  171. PIAYDA K, Veulemans V, Kelm M, Zeus T, et al
    Transcaval aortic valve implantation through a partially thrombosed infrarenal aortic aneurysm.
    Eur Heart J. 2019 Mar 27. pii: 5420568. doi: 10.1093.
    PubMed    


  172. MIURA M, Gavazzoni M, Taramasso M, Maisano F, et al
    Recurrent tricuspid regurgitation due to valve migration after transcatheter tricuspid valve replacement.
    Eur Heart J. 2019 Mar 20. pii: 5416181. doi: 10.1093.
    PubMed    


  173. GRABHER F, Hamm W, Massberg S, Orban M, et al
    Uncommon cause of progressive dyspnoea 12 years after coronary artery bypass surgery.
    Eur Heart J. 2019 Mar 12. pii: 5377349. doi: 10.1093.
    PubMed    


    February 2019
  174. OLDGREN J, Steg PG, Hohnloser SH, Lip GYH, et al
    Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.
    Eur Heart J. 2019 Feb 21. pii: 5359476. doi: 10.1093.
    PubMed     Abstract available


  175. TURGEON RD, Althouse AD
    Inappropriate inclusion of multiple studies in a meta-analysis of randomized controlled trials of atorvastatin loading prior to percutaneous coronary intervention for acute coronary syndrome.
    Eur Heart J. 2019 Feb 20. pii: 5345134. doi: 10.1093.
    PubMed    


  176. LUSCHER TF, Davies A
    Inclusion of multiple inappropriate studies in a meta-analysis of randomized controlled trials of atorvastatin loading prior to percutaneous coronary intervention for acute coronary syndrome: editor's response.
    Eur Heart J. 2019 Feb 20. pii: 5345135. doi: 10.1093.
    PubMed    


  177. ZHU SJ, Thondapu V, Poon EKW, Serruys PW, et al
    Computational particle tracking to model platelet behaviour near malapposed coronary stent struts.
    Eur Heart J. 2019 Feb 15. pii: 5321137. doi: 10.1093.
    PubMed    



  178. Corrigendum to: Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patie
    Eur Heart J. 2019 Feb 7. pii: 5309035. doi: 10.1093.
    PubMed    


    January 2019
  179. BARTEL T, Muller S
    Concomitant mitral stenosis may be associated with low flow: what it means and how it potentially impacts on transcatheter aortic valve replacement.
    Eur Heart J. 2019 Jan 30. pii: 5304402. doi: 10.1093.
    PubMed    


  180. WELZ A, Heinemann MK, Diegeler A
    Outcome after transvascular transcatheter aortic valve implantation in 2016: a closer look.
    Eur Heart J. 2019 Jan 25. pii: 5301476. doi: 10.1093.
    PubMed    


  181. SEIFFERT M, Walther T, Hamm C, Falk V, et al
    The DEDICATE Trial: An independent all-comers trial of transcatheter aortic valve implantation vs. surgical aortic valve replacement in patients at low to intermediate operative risk is recruiting patients.
    Eur Heart J. 2019;40:331-333.
    PubMed    


  182. CREA F, Bairey Merz CN, Beltrame JF, Berry C, et al
    Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization.
    Eur Heart J. 2019 Jan 4. pii: 5273474. doi: 10.1093.
    PubMed     Abstract available


  183. YE Z, Lu H, Su Q, Long M, et al
    Short-term and long-term effects of a loading dose of atorvastatin before percutaneous coronary intervention on major adverse cardiovascular events in patients with acute coronary syndrome: a meta-analysis of 13 randomized controlled trials.
    Eur Heart J. 2019 Jan 3. pii: 5272474. doi: 10.1093.
    PubMed     Abstract available


  184. YOSHIKAWA Y, Kimura T
    Percutaneous coronary intervention in stable coronary artery disease: still in equipoise?
    Eur Heart J. 2019 Jan 2. pii: 5272354. doi: 10.1093.
    PubMed    


  185. DUDEK D, Dziewierz A, Stone G, Wijns W, et al
    The year in cardiology 2018: coronary interventions.
    Eur Heart J. 2019 Jan 2. pii: 5265297. doi: 10.1093.
    PubMed    


  186. WOJAKOWSKI W, Baumgartner H
    The year in cardiology 2018: valvular heart disease.
    Eur Heart J. 2019 Jan 2. pii: 5265301. doi: 10.1093.
    PubMed    


    December 2018
  187. ZIMMERMANN FM, Omerovic E, Fournier S, Kelbaek H, et al
    Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data.
    Eur Heart J. 2018 Dec 28. pii: 5265290. doi: 10.1093.
    PubMed     Abstract available


  188. ASAMI M, Windecker S, Praz F, Lanz J, et al
    Transcatheter aortic valve replacement in patients with concomitant mitral stenosis.
    Eur Heart J. 2018 Dec 28. pii: 5265291. doi: 10.1093.
    PubMed     Abstract available


  189. SEEGER J, Kapadia SR, Kodali S, Linke A, et al
    Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis.
    Eur Heart J. 2018 Dec 24. pii: 5259357. doi: 10.1093.
    PubMed     Abstract available


  190. VLASTRA W, Chandrasekhar J, Munoz-Garcia AJ, Tchetche D, et al
    Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration.
    Eur Heart J. 2018 Dec 24. pii: 5259360. doi: 10.1093.
    PubMed     Abstract available


  191. BYRNE RA, Alfonso F, Schneider S, Maeng M, et al
    Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction
    Eur Heart J. 2018 Dec 5. pii: 5231946. doi: 10.1093.
    PubMed     Abstract available


  192. SONDERGAARD L
    Transcatheter aortic valve implantation in patients with longer life expectancy: what measures are needed?
    Eur Heart J. 2018 Dec 1. pii: 5224503. doi: 10.1093.
    PubMed    


    November 2018
  193. POTTS JE, Iliescu CA, Lopez Mattei JC, Martinez SC, et al
    Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United States.
    Eur Heart J. 2018 Nov 30. pii: 5221009. doi: 10.1093.
    PubMed     Abstract available


  194. URENA M, Himbert D
    Response: Acute haemolysis after transcatheter mitral valve implantation.
    Eur Heart J. 2018 Nov 29. pii: 5219611. doi: 10.1093.
    PubMed    


  195. JONVEAUX M, Gallet R, Mouillet G, Lim P, et al
    Acute haemolysis after transcatheter mitral valve implantation.
    Eur Heart J. 2018 Nov 29. pii: 5219667. doi: 10.1093.
    PubMed    


  196. CANDREVA A, Matter CM
    Is the amount of glow predicting the fire? Residual inflammatory risk after percutaneous coronary intervention.
    Eur Heart J. 2018 Nov 19. pii: 5173735. doi: 10.1093.
    PubMed    


  197. KASEL AM, Khan JM, Greenbaum AB, Michel JM, et al
    Intentional transcatheter laceration of the coronary cusp to prevent left main stem obstruction during transcatheter aortic valve implantation: first European experience with the BASILICA technique in a native aortic valve.
    Eur Heart J. 2018 Nov 16. pii: 5185126. doi: 10.1093.
    PubMed    


  198. BEKEREDJIAN R, Szabo G, Balaban U, Bleiziffer S, et al
    Patients at low surgical risk as defined by the Society of Thoracic Surgeons Score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY).
    Eur Heart J. 2018 Nov 16. pii: 5185128. doi: 10.1093.
    PubMed     Abstract available


  199. GOLWALA H, Cannon CP, Bhatt DL
    Reply to: Dual vs. triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Eur Heart J. 2018 Nov 5. pii: 5161202. doi: 10.1093.
    PubMed    


  200. GRAGNANO F, Calabro P, Valgimigli M
    Is triple antithrombotic therapy, or rather its duration and composition, the true culprit for the excess of bleeding events observed in patients with atrial fibrillation undergoing coronary intervention?
    Eur Heart J. 2018 Nov 5. pii: 5161206. doi: 10.1093.
    PubMed    


    October 2018
  201. FARAG M, Spinthakis N, Gue YX, Srinivasan M, et al
    Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study.
    Eur Heart J. 2018 Oct 30. pii: 5149701. doi: 10.1093.
    PubMed     Abstract available


  202. KALKMAN DN, Aquino M, Claessen BE, Baber U, et al
    Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.
    Eur Heart J. 2018 Oct 25. pii: 5144689. doi: 10.1093.
    PubMed     Abstract available


  203. YOON SH, Whisenant BK, Bleiziffer S, Delgado V, et al
    Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification.
    Eur Heart J. 2018 Oct 23. pii: 5143983. doi: 10.1093.
    PubMed     Abstract available


  204. CARREL T, Eberle B, Pasic M
    Cardioband to treat functional mitral regurgitation: a word of caution.
    Eur Heart J. 2018 Oct 22. pii: 5142408. doi: 10.1093.
    PubMed    


  205. MIURA M, Cuevas O, Taramasso M, Maisano F, et al
    Early recurrent mitral regurgitation due to MitraClip migration.
    Eur Heart J. 2018 Oct 4. pii: 5115407. doi: 10.1093.
    PubMed    


    September 2018
  206. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014.
    Eur Heart J. 2018 Sep 19. pii: 5103432. doi: 10.1093.
    PubMed     Abstract available


  207. SHAPIRA Y
    The Cardioband annuloplasty system: is it ready for prime time?
    Eur Heart J. 2018 Sep 12. pii: 5095986. doi: 10.1093.
    PubMed    


  208. STONE GW, Genereux P, Harrington RA, White HD, et al
    Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHA
    Eur Heart J. 2018 Sep 9. pii: 5093357. doi: 10.1093.
    PubMed     Abstract available


  209. MUKHERJEE D
    Coronary lesion complexity and the benefit of potent platelet inhibition after percutaneous coronary intervention.
    Eur Heart J. 2018 Sep 9. pii: 5093361. doi: 10.1093.
    PubMed    


  210. VON BARDELEBEN RS, Ruf T, Schulz E, Muenzel T, et al
    First percutaneous COMBO therapy of tricuspid regurgitation using direct annuloplasty and staged edge-to-edge repair in a surgical-like Clover technique.
    Eur Heart J. 2018 Sep 1. pii: 5089140. doi: 10.1093.
    PubMed    


    August 2018
  211. WINDECKER S, Neumann FJ, Juni P, Sousa-Uva M, et al
    Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease: an accompanying article of th
    Eur Heart J. 2018 Aug 25. pii: 5077827. doi: 10.1093.
    PubMed    


  212. BARTEL T, Khalil M, Traina M, Mihaljevic T, et al
    Percutaneous mitral annuloplasty complements clip implantation in functional mitral regurgitation.
    Eur Heart J. 2018 Aug 22. pii: 5078168. doi: 10.1093.
    PubMed    


  213. PATEL NN, Murphy GJ
    Restrictive transfusion practice in cardiac surgery patients is safe, but what transfusion threshold is safe for my patient?
    Eur Heart J. 2018 Aug 21. pii: 5077325. doi: 10.1093.
    PubMed    


  214. MESSIKA-ZEITOUN D, Nickenig G, Latib A, Kuck KH, et al
    Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes.
    Eur Heart J. 2018 Aug 16. pii: 5073985. doi: 10.1093.
    PubMed     Abstract available


  215. SHEHATA N, Mistry N, da Costa BR, Pereira TV, et al
    Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis.
    Eur Heart J. 2018 Aug 10. pii: 5070413. doi: 10.1093.
    PubMed     Abstract available


  216. POLOVINA M, Hindricks G, Maggioni A, Piepoli M, et al
    Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation.
    Eur Heart J. 2018 Aug 7. pii: 5067645. doi: 10.1093.
    PubMed     Abstract available


    July 2018
  217. VARENNE O, Sinnaeve PR
    De-escalation of antiplatelet treatment after percutaneous coronary interventions for acute coronary syndromes: is less more?
    Eur Heart J. 2018 Jul 24. pii: 5057993. doi: 10.1093.
    PubMed    


    June 2018
  218. GARCIA-GARCIA HM, McFadden EP, Farb A, Mehran R, et al
    Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
    Eur Heart J. 2018;39:2192-2207.
    PubMed     Abstract available


  219. SIBBING D, Gross L, Trenk D, Jacobshagen C, et al
    Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trial.
    Eur Heart J. 2018 Jun 14. pii: 5037998. doi: 10.1093.
    PubMed     Abstract available


  220. KEREIAKES DJ
    Healing by design: in vivo insights following contemporary coronary stent deployment.
    Eur Heart J. 2018 Jun 13. pii: 5037243. doi: 10.1093.
    PubMed    


    May 2018
  221. IBANEZ B, Halvorsen S, Roffi M, Bueno H, et al
    Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force.
    Eur Heart J. 2018 May 29. pii: 5020748. doi: 10.1093.
    PubMed    


  222. RABER L, Mintz GS, Koskinas KC, Johnson TW, et al
    Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions: Endorsed by the Chinese Society of Cardiology.
    Eur Heart J. 2018 May 22. pii: 5001185. doi: 10.1093.
    PubMed     Abstract available


  223. CREMER PC, Zhang Y, Alu M, Rodriguez LL, et al
    The incidence and prognostic implications of worsening right ventricular function after surgical or transcatheter aortic valve replacement: insights from PARTNER IIA.
    Eur Heart J. 2018 May 8. pii: 4993744. doi: 10.1093.
    PubMed     Abstract available


  224. MEIER B, Kaltenbach M
    The world's first 2 coronary angioplasty patients.
    Eur Heart J. 2018;39:1588-1589.
    PubMed    


    April 2018
  225. PILGRIM T, Windecker S
    Expansion of transcatheter aortic valve implantation: new indications and socio-economic considerations.
    Eur Heart J. 2018 Apr 26. pii: 4986946. doi: 10.1093.
    PubMed    


  226. MAHMOUD KD, Jolly SS, James S, Dzavik V, et al
    Clinical impact of direct stenting and interaction with thrombus aspiration in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Thrombectomy Trialists Collaboration.
    Eur Heart J. 2018 Apr 21. pii: 4975836. doi: 10.1093.
    PubMed     Abstract available


  227. GOLWALA HB, Cannon CP, Steg PG, Doros G, et al
    Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials.
    Eur Heart J. 2018 Apr 13. pii: 4970508. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  228. HULME W, Sperrin M, Curzen N, Kinnaird T, et al
    Operator volume is not associated with mortality following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society registry.
    Eur Heart J. 2018 Mar 22. pii: 4951577. doi: 10.1093.
    PubMed     Abstract available


  229. CAPODANNO D, Buccheri S
    Operator volume and mortality in percutaneous coronary intervention: a call for better competency metrics.
    Eur Heart J. 2018 Mar 22. pii: 4951529. doi: 10.1093.
    PubMed    


  230. NICHOLLS M
    Andre Simon, cardiac & transplant surgeon.
    Eur Heart J. 2018;39:974-975.
    PubMed    


  231. AUFFRET V, Cottin Y, Leurent G, Gilard M, et al
    Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
    Eur Heart J. 2018 Mar 15. pii: 4938779. doi: 10.1093.
    PubMed     Abstract available


  232. RUSINARU D, Bohbot Y, Ringle A, Marechaux S, et al
    Impact of low stroke volume on mortality in patients with severe aortic stenosis and preserved left ventricular ejection fraction.
    Eur Heart J. 2018 Mar 13. pii: 4934158. doi: 10.1093.
    PubMed     Abstract available


  233. RAHHAB Z, Ren B, de Jaegere PPT, Van Mieghem NMDA, et al
    Kissing balloon technique to secure the neo-left ventricular outflow tract in transcatheter mitral valve implantation.
    Eur Heart J. 2018 Mar 6. pii: 4922636. doi: 10.1093.
    PubMed    


  234. AFZAL S, Kleinebrecht L, Hellhammer K, Veulemans V, et al
    First-in-man: successful interventional closure of severe paravalvular leakage after surgical rapid deployment aortic valve replacement.
    Eur Heart J. 2018 Mar 5. pii: 4920929. doi: 10.1093.
    PubMed    


    February 2018
  235. SCHOLZ KH, Maier SKG, Maier LS, Lengenfelder B, et al
    Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.
    Eur Heart J. 2018 Feb 14. pii: 4855284. doi: 10.1093.
    PubMed     Abstract available


  236. VAN ROSENDAEL PJ, Delgado V, Bax JJ
    Pacemaker implantation rate after transcatheter aortic valve implantation with early and new-generation devices: a systematic review.
    Eur Heart J. 2018 Feb 6. pii: 4840597. doi: 10.1093.
    PubMed     Abstract available


    January 2018
  237. ZEITOUNI M, Silvain J, Guedeney P, Kerneis M, et al
    Periprocedural myocardial infarction and injury in elective coronary stenting.
    Eur Heart J. 2018 Jan 20. pii: 4815728. doi: 10.1093.
    PubMed     Abstract available


  238. SANGEN H, Imori Y, Tara S, Yamamoto T, et al
    Haemodynamic deterioration due to intra-aortic balloon counterpulsation in takotsubo cardiomyopathy.
    Eur Heart J. 2018 Jan 16. pii: 4812642. doi: 10.1093.
    PubMed    


  239. SMITH CR
    Emergency cardiac surgery following TAVI: implications for the future.
    Eur Heart J. 2018 Jan 8. pii: 4792978. doi: 10.1093.
    PubMed    


  240. KRISTENSEN SD, Maeng M, Capodanno D, Wijns W, et al
    The year in cardiology 2017: coronary interventions.
    Eur Heart J. 2018 Jan 2. pii: 4781700. doi: 10.1093.
    PubMed    


  241. IUNG B, Delgado V, Lazure P, Murray S, et al
    Educational needs and application of guidelines in the management of patients with mitral regurgitation. A European mixed-methods study.
    Eur Heart J. 2018 Jan 2. pii: 4782671. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  242. EGGEBRECHT H, Vaquerizo B, Moris C, Bossone E, et al
    Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI).
    Eur Heart J. 2017 Dec 14. pii: 4745749. doi: 10.1093.
    PubMed     Abstract available


  243. GAEDE L, Blumenstein J, Liebetrau C, Dorr O, et al
    Outcome after transvascular transcatheter aortic valve implantation in 2016.
    Eur Heart J. 2017 Dec 8. pii: 4710062. doi: 10.1093.
    PubMed     Abstract available


  244. LUSCHER TF
    Managing aortic stenosis with TAVI or surgery: risk assessement and long-term outcome.
    Eur Heart J. 2017;38:3327-3329.
    PubMed    


    November 2017
  245. ALKHOULI M, Carpenter E, Tarabishy A, Sengupta P, et al
    Annular rupture during transcatheter aortic valve replacement: novel treatment with amplatzer vascular plugs.
    Eur Heart J. 2017 Nov 13. doi: 10.1093.
    PubMed    


  246. LUSCHER TF
    Optimizing percutaneous coronary interventions: Heart Team, SYNTAX II Score, physiology and imaging guidance, modern stents, and guideline-based medication.
    Eur Heart J. 2017;38:3109-3113.
    PubMed    


  247. KUBO T, Shinke T, Okamura T, Hibi K, et al
    Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results.
    Eur Heart J. 2017;38:3139-3147.
    PubMed     Abstract available


    October 2017
  248. FENG Y, Zhao ZG, Baccaro J, Zeng MF, et al
    First-in-man implantation of a pre-packaged self-expandable dry-tissue transcatheter aortic valve.
    Eur Heart J. 2017 Oct 31. doi: 10.1093.
    PubMed    


  249. VAHANIAN A, Iung B
    Predicting the outcome of degenerative mitral regurgitation: a step forward but still a long way to go!
    Eur Heart J. 2017 Oct 25. doi: 10.1093.
    PubMed    


  250. CASTANO A, Narotsky DL, Hamid N, Khalique OK, et al
    Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
    Eur Heart J. 2017;38:2879-2887.
    PubMed     Abstract available


  251. GARGIULO P, Perrone-Filardi P
    Dangerous relationships: aortic stenosis and transthyretin cardiac amyloidosis.
    Eur Heart J. 2017;38:2888-2889.
    PubMed    


    September 2017
  252. LUSCHER TF
    From Cinderella to centre stage: valvular heart disease on the move.
    Eur Heart J. 2017;38:2693-2695.
    PubMed    


  253. LEU HB, Chang HH, Lin SM, Chen YH, et al
    Double trouble for transcatheter aortic valve implantation: a patient with no vascular access and high-risk features for bilateral coronary obstruction.
    Eur Heart J. 2017;38:2787.
    PubMed    


  254. IUNG B, Vahanian A
    Coronary obstruction: a rare but devastating complication during transcatheter aortic valve-in-valve implantation.
    Eur Heart J. 2017 Sep 6. doi: 10.1093.
    PubMed    


    August 2017
  255. BYRNE RA, Stefanini GG, Capodanno D, Onuma Y, et al
    Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary.
    Eur Heart J. 2017 Aug 28. doi: 10.1093.
    PubMed     Abstract available


  256. ESCANED J, Collet C, Ryan N, Luigi De Maria G, et al
    Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed     Abstract available


  257. BAUMGARTNER H, Falk V, Bax JJ, De Bonis M, et al
    2017 ESC/EACTS Guidelines for the management of valvular heart disease: The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed    


  258. TARANTINI G, Nai Fovino L, Gersh BJ
    Transcatheter aortic valve implantation in lower-risk patients: what is the perspective?
    Eur Heart J. 2017 Aug 24. doi: 10.1093.
    PubMed     Abstract available


  259. RIBEIRO HB, Rodes-Cabau J, Blanke P, Leipsic J, et al
    Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry.
    Eur Heart J. 2017 Aug 14. doi: 10.1093.
    PubMed     Abstract available


  260. D'ASCENZO F, Iannaccone M, Saint-Hilary G, Bertaina M, et al
    Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients.
    Eur Heart J. 2017 Aug 11. doi: 10.1093.
    PubMed     Abstract available


  261. SCHULZ E, Beiras-Fernandez A, Rohsbach U, von Bardeleben RS, et al
    Successful transcatheter aortic valve-in-valve implantation in a patient having a chronic type A aortic dissection.
    Eur Heart J. 2017 Aug 10. doi: 10.1093.
    PubMed    


  262. TAMBURINO C, Barbanti M
    Transcatheter aortic valve implantation with a mechanical-expandable device: when perfection is hung on a 'wire'.
    Eur Heart J. 2017 Aug 1. doi: 10.1093.
    PubMed    


    July 2017
  263. DE WAHA S, Patel MR, Granger CB, Ohman EM, et al
    Relationship between microvascular obstruction and adverse events following primary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.
    Eur Heart J. 2017 Jul 28. doi: 10.1093.
    PubMed     Abstract available


  264. ALFONSO F, Prati F
    Optical coherence tomography or intravascular ultrasound to optimize coronary stent implantation.
    Eur Heart J. 2017 Jul 25. doi: 10.1093.
    PubMed    


  265. VRANCKX P, Windecker S, Welsh RC, Valgimigli M, et al
    Thrombo-embolic prevention after transcatheter aortic valve implantation.
    Eur Heart J. 2017 Jul 25. doi: 10.1093.
    PubMed     Abstract available


  266. TREIBEL TA, Lopez B, Gonzalez A, Menacho K, et al
    Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients.
    Eur Heart J. 2017 Jul 22. doi: 10.1093.
    PubMed     Abstract available


  267. SONDERGAARD L, De Backer O, Kofoed KF, Jilaihawi H, et al
    Natural history of subclinical leaflet thrombosis affecting motion in bioprosthetic aortic valves.
    Eur Heart J. 2017;38:2201-2207.
    PubMed     Abstract available


  268. GENEREUX P, Pibarot P, Redfors B, Mack MJ, et al
    Staging classification of aortic stenosis based on the extent of cardiac damage.
    Eur Heart J. 2017 Jul 21. doi: 10.1093.
    PubMed     Abstract available


  269. CHAMBERS JB, Prendergast B, Iung B, Rosenhek R, et al
    Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint.
    Eur Heart J. 2017;38:2177-2183.
    PubMed    


  270. WHITLOCK RP, McClure GR, Eikelboom JW
    Aortic valve replacement in younger patients.
    Eur Heart J. 2017 Jul 14. doi: 10.1093.
    PubMed    


    June 2017
  271. FALK V, Wohrle J, Hildick-Smith D, Bleiziffer S, et al
    Safety and efficacy of a repositionable and fully retrievable aortic valve used in routine clinical practice: the RESPOND Study.
    Eur Heart J. 2017 Jun 22. doi: 10.1093.
    PubMed     Abstract available


  272. GERCKENS U, Tamburino C, Bleiziffer S, Bosmans J, et al
    Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study.
    Eur Heart J. 2017 Jun 13. doi: 10.1093.
    PubMed     Abstract available


  273. WENDLER O, Schymik G, Treede H, Baumgartner H, et al
    SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve.
    Eur Heart J. 2017 Jun 12. doi: 10.1093.
    PubMed     Abstract available


  274. SCHULZ E, Tamm A, Kasper-Konig W, Beiras-Fernandez A, et al
    Transapical implantation of a transcatheter aortic valve prosthesis into a mitral annuloplasty ring guided by real-time three-dimensional cardiac computed tomography-fluoroscopy fusion imaging.
    Eur Heart J. 2017 Jun 12. doi: 10.1093.
    PubMed    


    May 2017
  275. SUKUL D, Bach DS
    Readmissions after transcatheter aortic valve implantation. What are they doing right? How can we do better?
    Eur Heart J. 2017 May 19. doi: 10.1093.
    PubMed    


  276. ZITTERMANN A, Ernst JB, Prokop S, Fuchs U, et al
    Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D daily.
    Eur Heart J. 2017 May 12. doi: 10.1093.
    PubMed     Abstract available


  277. KORTELAND NM, Etnel JRG, Arabkhani B, Mokhles MM, et al
    Mechanical aortic valve replacement in non-elderly adults: meta-analysis and microsimulation.
    Eur Heart J. 2017 May 10. doi: 10.1093.
    PubMed     Abstract available


    April 2017
  278. FRANGIEH AH, Kasel AM
    TAVI in Bicuspid Aortic Valves 'Made Easy'.
    Eur Heart J. 2017;38:1177-1181.
    PubMed    


  279. HEAD SJ, Celik M, Kappetein AP
    Mechanical versus bioprosthetic aortic valve replacement.
    Eur Heart J. 2017 Apr 20. doi: 10.1093.
    PubMed     Abstract available


  280. FRANZONE A, Pilgrim T, Arnold N, Heg D, et al
    Rates and predictors of hospital readmission after transcatheter aortic valve implantation.
    Eur Heart J. 2017 Apr 18. doi: 10.1093.
    PubMed     Abstract available


  281. CAVALCANTE R, Sotomi Y, Mancone M, Whan Lee C, et al
    Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials.
    Eur Heart J. 2017 Apr 18. doi: 10.1093.
    PubMed     Abstract available


  282. PALMERINI T, Della Riva D, Benedetto U, Bacchi Reggiani L, et al
    Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
    Eur Heart J. 2017;38:1034-1043.
    PubMed     Abstract available


    March 2017
  283. VOLLEMA EM, Kong WK, Katsanos S, Kamperidis V, et al
    Transcatheter aortic valve thrombosis: the relation between hypo-attenuated leaflet thickening, abnormal valve haemodynamics, and stroke.
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    PubMed     Abstract available


  284. RUILE P, Neumann FJ
    Hypo-attenuated leaflet thickening of transcatheter aortic valves: jeopardy or epiphenomenon?
    Eur Heart J. 2017 Mar 27. doi: 10.1093.
    PubMed    


  285. VAN ROSENDAEL PJ, Kamperidis V, Kong WK, van Rosendael AR, et al
    Computed tomography for planning transcatheter tricuspid valve therapy.
    Eur Heart J. 2017;38:665-674.
    PubMed     Abstract available


  286. TARAMASSO M, Pozzoli A, Guidotti A, Nietlispach F, et al
    Percutaneous tricuspid valve therapies: the new frontier.
    Eur Heart J. 2017;38:639-647.
    PubMed     Abstract available


  287. STEPHAN VON BARDELEBEN R, Tamm A, Emrich T, Munzel T, et al
    Percutaneous transvenous direct annuloplasty of a human tricuspid valve using the Valtech Cardioband.
    Eur Heart J. 2017;38:690.
    PubMed    


    February 2017
  288. NIELSEN LH, Botker HE, Sorensen HT, Schmidt M, et al
    Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: a Danish multicentre cohort study.
    Eur Heart J. 2017;38:413-421.
    PubMed     Abstract available


  289. SINNING JM
    Trying to square the circle? Integration of computed tomography data for the evaluation of mitral regurgitation.
    Eur Heart J. 2017 Feb 3. doi: 10.1093.
    PubMed    


    January 2017
  290. VAN ROSENDAEL PJ, van Wijngaarden SE, Kamperidis V, Kong WK, et al
    Integrated imaging of echocardiography and computed tomography to grade mitral regurgitation severity in patients undergoing transcatheter aortic valve implantation.
    Eur Heart J. 2017 Jan 10. pii: ehw612. doi: 10.1093.
    PubMed     Abstract available


  291. KUWATA S, Taramasso M, Nietlispach F, Maisano F, et al
    Transcatheter tricuspid valve repair toward a surgical standard: first-in-man report of direct annuloplasty with a cardioband device to treat severe functional tricuspid regurgitation.
    Eur Heart J. 2017 Jan 10. pii: ehw660. doi: 10.1093.
    PubMed    


  292. DEBONNAIRE P, van der Kley F, Ajmone Marsan N, Delgado V, et al
    MitraClip improves mitral valve geometry in complex organic mitral regurgitation: insights from three-dimensional-echocardiography.
    Eur Heart J. 2017 Jan 10. pii: ehw645. doi: 10.1093.
    PubMed    


  293. ALFIERI O, Vahanian A
    The year in cardiology 2016: valvular heart disease.
    Eur Heart J. 2017 Jan 2. pii: ehw636. doi: 10.1093.
    PubMed    


    December 2016
  294. ABRAMOWITZ Y, Kazuno Y, Chakravarty T, Kawamori H, et al
    Concomitant mitral annular calcification and severe aortic stenosis: prevalence, characteristics and outcome following transcatheter aortic valve replacement.
    Eur Heart J. 2016 Dec 30. pii: ehw594. doi: 10.1093.
    PubMed     Abstract available


  295. LUSCHER TF
    Aortic stenosis: expanding treatment options.
    Eur Heart J. 2016;37:3483-3485.
    PubMed    


    November 2016
  296. KUWATA S, Taramasso M, Maisano F, Weber A, et al
    Infective endocarditis after transcatheter aortic valve implantation with LOTUS valve.
    Eur Heart J. 2016.
    PubMed    


    October 2016
  297. TARANTINI G, Mojoli M, Urena M, Vahanian A, et al
    Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome.
    Eur Heart J. 2016.
    PubMed     Abstract available


  298. LESEVIC H, Frangieh AH, Kasel AM, Ott I, et al
    Successful percutaneous edge-to-edge repair in degenerative tricuspid valve regurgitation using the MitraClip system.
    Eur Heart J. 2016.
    PubMed    


    September 2016
  299. MOAT N, Brecker S
    Transfemoral TAVI is superior to SAVR in elderly high-risk patients with symptomatic severe aortic stenosis!
    Eur Heart J. 2016.
    PubMed    


  300. LUSCHER TF
    Aortic valve disease 2016: evaluation for and outcome of TAVI and surgery.
    Eur Heart J. 2016;37:2615-7.
    PubMed    


  301. LUSCHER TF
    From heart failure to transplantation: genes, miRNAs, and biomarkers.
    Eur Heart J. 2016;37:2561-3.
    PubMed    


    August 2016
  302. LUSCHER TF
    Atrial fibrillation and stroke: risk factors, anticoagulation, and left atrial appendage occluders.
    Eur Heart J. 2016;37:2443-5.
    PubMed    


    July 2016
  303. SIONTIS GC, Praz F, Pilgrim T, Mavridis D, et al
    Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of severe aortic stenosis: a meta-analysis of randomized trials.
    Eur Heart J. 2016.
    PubMed     Abstract available


    June 2016
  304. VAHANIAN A, Nataf P
    Let us preserve the harmonious development of transcatheter aortic valve implantation!
    Eur Heart J. 2016.
    PubMed    


    May 2016
  305. PONIKOWSKI P, Voors AA, Anker SD, Bueno H, et al
    2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contributio
    Eur Heart J. 2016.
    PubMed    


  306. FIGULLA HR, Webb JG, Lauten A, Feldman T, et al
    The transcatheter valve technology pipeline for treatment of adult valvular heart disease.
    Eur Heart J. 2016.
    PubMed     Abstract available


    April 2016
  307. ABDELGHANI M, Soliman OI, Schultz C, Vahanian A, et al
    Adjudicating paravalvular leaks of transcatheter aortic valves: a critical appraisal.
    Eur Heart J. 2016.
    PubMed     Abstract available


    March 2016
  308. CLAVEL MA, Magne J, Pibarot P
    Low-gradient aortic stenosis.
    Eur Heart J. 2016.
    PubMed     Abstract available


  309. KODALI S, Thourani VH, White J, Malaisrie SC, et al
    Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis.
    Eur Heart J. 2016.
    PubMed     Abstract available


  310. EGBE AC, Poterucha JT, Warnes CA
    Mixed aortic valve disease: midterm outcome and predictors of adverse events.
    Eur Heart J. 2016.
    PubMed     Abstract available


    February 2016
  311. SCHUELER R, Werner N, Nickenig G, Hammerstingl C, et al
    Catheter-based complete "Alfieri-Stich" via interventional annuloplasty and edge-to-edge repair for degenerative mitral regurgitation.
    Eur Heart J. 2016.
    PubMed    


    January 2016
  312. PURI R, Iung B, Cohen DJ, Rodes-Cabau J, et al
    TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation.
    Eur Heart J. 2016.
    PubMed     Abstract available


  313. ZUK K, Stortecky S, Wenaweser P, Huber C, et al
    Mechanical aortic valves and massive mitral calcifications should not preclude transcatheter mitral Valve-In-Ring TAVI device implantation.
    Eur Heart J. 2016.
    PubMed    


  314. SAMAD Z, Vora AN, Dunning A, Schulte PJ, et al
    Aortic valve surgery and survival in patients with moderate or severe aortic stenosis and left ventricular dysfunction.
    Eur Heart J. 2016.
    PubMed     Abstract available


  315. BUDTS W, Roos-Hesselink J, Radle-Hurst T, Eicken A, et al
    Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology.
    Eur Heart J. 2016.
    PubMed    


  316. CRESPO-LEIRO MG, Stypmann J, Schulz U, Zuckermann A, et al
    Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II.
    Eur Heart J. 2016.
    PubMed     Abstract available


    November 2015
  317. GLASER N, Jackson V, Holzmann MJ, Franco-Cereceda A, et al
    Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50-69 years.
    Eur Heart J. 2015.
    PubMed     Abstract available


    September 2015
  318. ARSALAN M, Walther T, Smith RL 2nd, Grayburn PA, et al
    Tricuspid regurgitation diagnosis and treatment.
    Eur Heart J. 2015.
    PubMed     Abstract available


    June 2015
  319. ARZT S, Wilbring M, Knaut M
    Turned, wedged, but still no feeling: asymptomatic late transcatheter aortic valve dislocation into the LVOT.
    Eur Heart J. 2015.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: